Home › Funds › Long Focus Capital Management, LLC › LAB

Long Focus Capital Management, LLC position in LAB

STANDARD BIOTOOLS INC · Industrials

Long Focus Capital Management, LLC reported holding 23,500,000 shares of LAB (STANDARD BIOTOOLS INC) in its Q2 2026 13F filing — a position valued at US$19.3M, representing 0.77% of its reported portfolio and ranking #41 among its reported holdings. Long Focus Capital Management, LLC has disclosed LAB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)23.50M sh
Reported value held$19.33M
Portfolio Weight0.77%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Long Focus Capital Management, LLC's LAB position evolved

Long Focus Capital Management, LLC first disclosed a stake in LAB in Q1 2025 at 6,700,000 shares (US$7.2M). The position peaked in Q2 2026 at 23,500,000 shares, worth US$19.3M. Across 6 filings, Long Focus Capital Management, LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 23,500,000 shares valued at US$19.3M — an increase of 7,484,279 shares quarter over quarter.. Notable position changes include a 50% increase in Q2 2025 (shares rose 8% over the following quarter), a 26% increase in Q1 2026 (shares fell 11% over the following quarter), a 47% increase in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 6.70M $7.24M New
Q2 2025 10.07M $12.08M Add
Q3 2025 11.36M $14.77M Add
Q4 2025 12.68M $16.23M Add
Q1 2026 16.02M $14.72M Add
Q2 2026 23.50M $19.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LAB and 13F data

LAB (STANDARD BIOTOOLS INC) is a Industrials company. 21 other funds we track also report a position in LAB — the largest reported positions include Casdin Capital (US$73.0M), MAK CAPITAL ONE LLC (US$23.7M), Hollow Brook Wealth Management LLC (US$4.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LAB

All LAB fund holders →

FAQ

How long has Long Focus Capital Management, LLC held LAB?

Long Focus Capital Management, LLC has disclosed LAB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Long Focus Capital Management, LLC's current position in LAB?

As of Q2 2026, Long Focus Capital Management, LLC holds 23.50M shares of LAB (STANDARD BIOTOOLS INC), valued at $19.33M, representing 0.77% of its reported portfolio and ranking #41.

Has Long Focus Capital Management, LLC been buying or selling LAB?

In the latest 13F filing (Q2 2026), Long Focus Capital Management, LLC increased its position in LAB. The position peaked in Q2 2026 at 23.50M shares.

Which other funds hold LAB?

Other major institutional holders of LAB include Casdin Capital, MAK CAPITAL ONE LLC, Hollow Brook Wealth Management LLC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.